AKT1 and breast carcinoma: This study provides evidence of a molecular mechanism for the radiosensitizer effect of MPSE, demonstrating that MPSE in combination with radiotherapy inhibits the radiation-induced EMT process by attenuating the PI3K/AKT and MAPK pathways and increasing therapeutic efficacy in breast cancer.